Citations

Clear

1031 citation(s) found for "Clark, AS".

Lithium Response in Bipolar Disorder is Associated with Focal Adhesion and PI3K-Akt Networks: A Multi-omics Replication Study
Ou, Anna , Adli, Mazda , Akiyama, Kazufumi , Akula, Nirmala , Amare, Azmeraw T. , Ardau, Raffaella , Arias, Bárbara , Aubry, Jean‐Michel , Bauer, Michael , Benabarre, Antonio , Bengesser, Susanne , Abesh, Bhattacharjee, Bui, Elise T. , Cervantes, Pablo , Chillotti, Caterina , Cichon, Sven , Clark, Scott R. , Cousins, David A. , Cruceanu, Cristiana , Degenhardt, Franziska , Ferensztajn‐Rochowiak, Ewa , Forstner, Andreas J. , Frisén, Louise , Frye, Mark A. , Gard, Sébastien, Grof, Paul , Gruber, Oliver , Kahn, Jean‐Pierre, Kassem, Layla, Kittel‐Schneider, Sarah , Dalkner, Nina , Laje, Gonzalo, Landén, Mikael , Lavebratt, Catharina , Leckband, Susan G. , López‐Jaramillo, Carlos , Maj, Mario , Mattheisen, Manuel , McCarthy, Michael J. , Mitjans, Marina , Mondimore, Francis M. , Nöthen, Markus M. , Ösby, Urban, Perlis, Roy H. , Pfennig, Andrea , Potash, James B. , Schalling, Martin , Schubert, Klaus Oliver , Schweizer, Barbara , Severino, Giovanni , Shekhtman, Tatyana , Shilling, Paul D. , Shimoda, Kazutaka , Simhandl, Christian , Slaney, Claire , Stamm, Thomas , Tighe, Sarah K., Volkert, Julia, Witt, Stephanie H. , Zandi, Peter P. , Zompo, Maria Del , Ou, Anna , Alda, Martin , Amare, Azmeraw , Arias, Bárbara , Bauer, M , Baune, Bernhard , Biernacka, Joanna , Chen, Hsi-Chung , Clark, Scott , Cruceanu, Cristiana , Czerski, Piotr , DePaulo, J Raymond , Etain, B , Forstner, Andreas J , Frye, Mark , Fullerton, Janice M , Garnham, Julie , Grigoroiu-Serbanescu, Maria , Hashimoto, Ryota , Hauser, Joanna , Heilbronner, Urs , Hou, Liping , Jamain, Stéphane , Kato, Tadafumi , Kuo, Po-Hsiu , Kusumi, Ichiro , Landén, Mikael , Lavebratt, Catharina , Leboyer, Marion , Marie-Claire, Cynthia , McMahon, Francis , Mitchell, Philip B , Mitjans, Marina , Nievergelt, Caroline M , Nöthen, Markus M , Novak, Tomas , Ozaki, Norio , Papiol, Sergi , Reif, Andreas , Reininghaus, Eva , Rietschel, Marcella , Rouleau, Guy Armand , Rybakowski, Janusz K , Schalling, Martin , Schofield, Peter R , Schubert, Klaus Oliver , Schulze, Thomas , Severino, Giovanni , Shilling, Paul , Shimoda, Kazutaka , Squassina, Alessio , Turecki, Gustavo , Vieta, E , Witt, Stephanie H , Wray, Naomi , Del Zompo, Maria , Cichon, Sven , López-Jaramillo, Carlos , Kittel-Schneider, Sarah , McCarthy, Michael , Perlis, Roy H , Kelsoe, John R , Jiang, Qingfei , Alda, Martin , Backlund, Lena , Banzato, Cláudio E. M. , Bellivier, Frank , Biernacka, Joanna M. , Chen, Guo‐Bo , Chen, Hsi‐Chung , Colom, Francesc , Czerski, Piotr M. , Dantas, Clarissa de Rosalmeida , Dayer, Alexandre G. , Étain, Bruno , Falkai, Peter , Fellendorf, Frederike T. , Fullerton, Janice M. , Goes, Fernando , Grigoroiu‐Serbânescu, Maria , Hashimoto, Ryota , Heilbronner, Urs , Herms, Stefan , Hoffmann, Per , Hofmann, Andrea , Jamain, Stéphane , Jiménez, Esther , Kato, Tadafumi , König, Barbara , Kuo, Po‐Hsiu , Dalkner, Nina , Leboyer, Marion , MacQUEEN, GLENDA M. , Manchia, Mirko , Martinsson, Lina , McElroy, Susan L. , McMahon, Francis J. , Monteleone, Palmiero , Novák, Tomáš , Ozaki, Norio , Papiol, Sergi , Reich‐Erkelenz, Daniela , Reif, Andreas , Schofield, Peter R. , Seemüller, Florian , Squassina, Alessio , Stopková, Pavla , Tortorella, Alfonso , Turecki, Gustavo , Vieta, Eduard , Wright, Adam, Young, Trevor

Mayo Clinic

No container title available | October 3, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-3258813/v1 | PMID 37886563 Get It

Abstract Lithium is the gold standard treatment for bipolar disorder (BD). However, its mechanism of action is incompletely understood, and prediction of treatment outcomes is limited. In our previous multi-omics study of the Pharmacogenomics of Bipolar Disorder (PGBD) sample combining transcriptomic and genomic data, we found that focal adhesion, the extracellular matrix (ECM), and PI3K-Akt signaling networks were associated with response to lithium. In this study, we replicated the results of our previous study using network propagation methods in a genome-wide association study of an independent sample of 2,039 patients from the International Consortium on Lithium Genetics (ConLiGen) study. We identified functional enrichment in focal adhesion and PI3K-Akt pathways, but we did not find an association with the ECM pathway. Our results suggest that deficits in the neuronal growth cone and PI3K-Akt signaling, but not in ECM proteins, may influence response to lithium in BD.
Evaluating the Impact of Pharmacist Dual Verification of Anticancer Therapy in the Modern Era
Stonerock, Devon S. , Clark, Kaylee M. , Shah, Vishal , Irvine, Clayton , Draper, Evan , Soefje, Scott A. , Clark, Kaylee, Irvine, Clayton C, Soefje, Scott A , Shah, Vishal , Clark, Kaylee

Mayo Clinic

Journal of Pharmacy Technology | September 29, 2023 | Volume: 39 | Issue: 6 | Pages: 281-285

10.1177/87551225231197346 | PMID 37974597 Get It

Background: Pharmacist order verification is a critical step in ensuring medication safety for patients. While the second pharmacist verification (SPV) before dispensing anticancer therapies has been a longstanding practice, its continued necessity in the context of modern electronic health systems lacks robust evidence. Objective: This study aimed to assess the frequency of interventions performed by a second pharmacist to determine the ongoing effectiveness of the SPV process. Methods: This retrospective chart review was conducted at the Mayo Clinic, encompassing all anticancer therapy orders that necessitated an SPV. The study period extended from January 1, 2019, to June 30, 2021, and included inpatient and outpatient anticancer orders. The quantification and reporting of alterations made to discrete order fields subsequent to initial pharmacist verification of clinical significance were performed, utilizing the total number of anticancer therapy orders as the denominator. Results: Approximately 300 000 anticancer therapy orders were screened for inclusion criteria and 2.6% (N = 7634) of orders were modified on the SPV. Most changes were in the categories of rate (N = 1962), order start time (N = 1219), and pharmacy communication note (N = 777). Dosing changes greater than 10% accounted for 0.03% (N = 99) of the orders, with 10 anticancer therapies responsible for more than 50% of these changes. Conclusion and relevance: This study represents the largest report on the impact of SPV in a modern era. Our results suggest the SPV may be valuable for a small proportion of chemotherapy orders but raises questions about the necessity for broad application of this practice.
Incidence Of Illnesses Among Team Usa Athletes Competing In The Beijing 2022 Winter Paralympic Games
Cali, Malia G. , Clark, Stephanie C., Hasley, Ike B., Larson, Emily G., Noble-Taylor, Kayle E., Finnoff, Jonathan T. , Clark, Stephanie C., McPherson, April L. , Robinson, David M. , Adams, William M.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 26, 2023 | Volume: 55 | Issue: 9S | Pages: 81-82

10.1249/01.mss.0000980448.16663.ff Get It

Incidence Of Injuries Among Team Usa Athletes Competing In The Beijing 2022 Winter Paralympic Games
Cali, Malia G. , Clark, Stephanie C., Hasley, Ike B., Larson, Emily G., Noble-Taylor, Kayle E., Adams, William M. , McPherson, April L. , Robinson, David M. , Finnoff, Jonathan T.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 26, 2023 | Volume: 55 | Issue: 9S | Pages: 80-80

10.1249/01.mss.0000980432.27799.f1 Get It

Incidence Of Injuries Among Team Usa Athletes Competing In The Beijing 2022 Winter Olympic Games
Noble-Taylor, Kayle E., Cali, Malia G. , Clark, Stephanie C., Hasley, Ike B., Larson, Emily G., Adams, William M. , McPherson, April L. , Robinson, David M. , Finnoff, Jonathan T.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 26, 2023 | Volume: 55 | Issue: 9S | Pages: 74-74

10.1249/01.mss.0000980392.16649.bc Get It

Incidence Of Illness Among Team Usa Athletes Competing In The 2022 Beijing Winter Olympic Games
Clark, Stephanie C., Cali, Malia G. , Hasley, Ike B., Larson, Emily G., Noble-Taylor, Kayle E., Adams, William M. , McPherson, April L. , Robinson, David M. , Finnoff, Jonathan T.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 26, 2023 | Volume: 55 | Issue: 9S | Pages: 79-79

10.1249/01.mss.0000980424.22415.75 Get It

Incidence Of Injuries And Illnesses Among Team Usa Staff Supporting The 2022 Beijing Winter Paralympic Games
Larson, Emily G., Cali, Malia G. , Clark, Stephanie C., Hasley, Ike B., Noble-Taylor, Kayle E., Adams, William M. , Clark, Stephanie C., McPherson, April L. , Robinson, David M. , Finnoff, Jonathan T.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 26, 2023 | Volume: 55 | Issue: 9S | Pages: 71-71

10.1249/01.mss.0000980364.38762.2b Get It

Incidence Of Injuries And Illnesses Among Team Usa Staff During The Beijing 2022 Winter Olympic Games
Hasley, Ike B., Cali, Malia G. , Clark, Stephanie C., Larson, Emily G., Noble-Taylor, Kayle E., Adams, William M. , Clark, Stephanie C., McPherson, April L. , Robinson, David M. , Finnoff, Jonathan T.

Mayo Clinic

Medicine & Science in Sports & Exercise | September 26, 2023 | Volume: 55 | Issue: 9S | Pages: 75-75

10.1249/01.mss.0000980400.52610.df Get It

Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease
Huang, Yannan , Sompii‐Montgomery, Laura, Patti, Jessica, Pickering, Alex, Yasin, Shima , Gao, Denny , Abdul‐Aziz, Rabheh , Behrens, Edward M. , Co, Dominic O. , Collins, Kathleen , Eberhard, B. Anne, Friedman, Monica, Graham, T. Brent , Hahn, Timothy , Hersh, Aimee O. , Hobday, Patricia M. , Holland, Michael J., Huggins, Jennifer , Lu, Pai‐Yue, Mannion, Melissa L. , Manos, Cynthia K., Neely, Jessica , Ramirez, Andrea, Reinhardt, Adam, Riskalla, Mona , Santiago, L E, Ting, Tracy V. , Grom, Alexei A. , Towe, C. , Gao, Denny , Canna, Scott , Hersh, Aimee O , Mannion, Melissa L , Neely, Jessica , Schulert, Grant S , Behrens, Edward M , Do, Thuy, Baker, Elizabeth K. , Clark, Matthew, Collins, Kathleen , Holland, Michael J., Onel, Karen , Orandi, Amir B. , Stoll, Matthew Laurence

Mayo Clinic

Arthritis Care & Research | September 11, 2023 | Volume: 76 | Issue: 3 | Pages: 328-339

10.1002/acr.25234 | PMID 37691306 Get It

Objective Systemic juvenile idiopathic arthritis–associated lung disease (SJIA‐LD) is a life‐threatening disease complication. Key questions remain regarding clinical course and optimal treatment approaches. The objectives of the study were to detail management strategies after SJIA‐LD detection, characterize overall disease courses, and measure long‐term outcomes. Methods This was a prospective cohort study. Clinical data were abstracted from the electronic medical record, including current clinical status and changes since diagnosis. Serum biomarkers were determined and correlated with presence of LD. Results We enrolled 41 patients with SJIA‐LD, 85% with at least one episode of macrophage activation syndrome and 41% with adverse reactions to a biologic. Although 93% of patients were alive at last follow‐up (median 2.9 years), 37% progressed to requiring chronic oxygen or other ventilator support, and 65% of patients had abnormal overnight oximetry studies, which changed over time. Eighty‐four percent of patients carried the HLA‐DRB1*15 haplotype, significantly more than patients without LD. Patients with SJIA‐LD also showed markedly elevated serum interleukin‐18 (IL‐18), variable C‐X‐C motif chemokine ligand 9 (CXCL9), and significantly elevated matrix metalloproteinase 7. Treatment strategies showed variable use of anti–IL‐1/6 biologics and addition of other immunomodulatory treatments and lung‐directed therapies. We found a broad range of current clinical status independent of time from diagnosis or continued biologic treatment. Multidomain measures of change showed imaging features were the least likely to improve with time. Conclusion Patients with SJIA‐LD had highly varied courses, with lower mortality than previously reported but frequent hypoxia and requirement for respiratory support. Treatment strategies were highly varied, highlighting an urgent need for focused clinical trials.
Amyloid and tau‐PET in early‐onset AD: Baseline data from the Longitudinal Early‐onset Alzheimer's Disease Study (LEADS)
Cho, Hanna , Mundada, Nidhi S. , Apostolova, Liana G. , Carrillo, María C. , Shankar, Ranjani , Amuiri, Alinda, Zeltzer, Ehud , Windon, Charles , Soleimani‐Meigooni, David N. , Tanner, Jeremy A. , Lesman‐Segev, Orit H. , Aisen, Paul , Eloyan, Ani , Lee, Hye Sun , Hammers, Dustin B. , Kirby, Kala, Dage, Jeffrey L. , Fagan, Anne M. , Grinberg, Lea T. , Jack, Clifford R. , Kramer, Joel H. , Kukull, Walter A. , Vemuri, Prashanthi , Day, Gregory S. , Duara, Ranjan , Graff‐Radford, Neill R. , Masdeu, Joseph C. , Mendez, Mario F. , Onyike, Chiadi U. , Riddle, Meghan , Rogalskı, Emily , Salloway, Stephen , Sha, Sharon, Turner, Raymond Scott , Wingo, Thomas S. , Joie, Renaud La , Rabinovici, Gil D. , Jack, Clifford R , Vemuri, Prashanthi , Day, Gregory S , La Joie, Renaud , Grinberg, Lea , Rabinovici, Gil D , Windon, Charles , Wingo, Thomas S , Dage, Jeffrey L , Lawhn-Heath, Courtney A. , Hammers, Dustin B , Foroud, Tatiana , Murray, Melissa E. , Nudelman, Kelly , Toga, Arthur W. , Atri, Alireza , Duara, Ranjan , Honig, Lawrence S. , Jones, David T. , Masdeu, Joseph C , Musiek, Erik , Sha, Sharon J. , Wolk, David A. , Koeppe, Robert A. , Iaccarino, Leonardo , Dickerson, Bradford Clark

Mayo Clinic

Alzheimer's & Dementia | September 10, 2023 | Volume: 19 | Issue: S9 | Pages: No page available

10.1002/alz.13453 | PMID 37690109 Get It

Abstract INTRODUCTION We aimed to describe baseline amyloid‐beta (Aβ) and tau‐positron emission tomograrphy (PET) from Longitudinal Early‐onset Alzheimer's Disease Study (LEADS), a prospective multi‐site observational study of sporadic early‐onset Alzheimer's disease (EOAD). METHODS We analyzed baseline [18F]Florbetaben (Aβ) and [18F]Flortaucipir (tau)‐PET from cognitively impaired participants with a clinical diagnosis of mild cognitive impairment (MCI) or AD dementia aged < 65 years. Florbetaben scans were used to distinguish cognitively impaired participants with EOAD (Aβ+) from EOnonAD (Aβ−) based on the combination of visual read by expert reader and image quantification. RESULTS 243/321 (75.7%) of participants were assigned to the EOAD group based on amyloid‐PET; 231 (95.1%) of them were tau‐PET positive (A+T+). Tau‐PET signal was elevated across cortical regions with a parietal‐predominant pattern, and higher burden was observed in younger and female EOAD participants. DISCUSSION LEADS data emphasizes the importance of biomarkers to enhance diagnostic accuracy in EOAD. The advanced tau‐PET binding at baseline might have implications for therapeutic strategies in patients with EOAD. HIGHLIGHTS 72% of patients with clinical EOAD were positive on both amyloid‐ and tau‐PET. Amyloid‐positive patients with EOAD had high tau‐PET signal across cortical regions. In EOAD, tau‐PET mediated the relationship between amyloid‐PET and MMSE. Among EOAD patients, younger onset and female sex were associated with higher tau‐PET.